jungle.java

OMG it is finally here! Winston’s name tag has arrived and now we are ready for 2024 😁🤭💚 $MSOS #WinstonMSOSbully CC: @InvestinginCan1 @HammanShares @mpadvisorshares @LorkeStevie

There was an inflow today for the @AdvisorShares $MSOS ETF consisting of 1,200,000 share creates valued at $4,620,000. Here are the changes made to the holdings for March 19, 2026 💰 position ($8.11M) vs ($9.70M) Current NAV $3.85 Closing Price $3.82 $MSOX NAV $2.57 Closing Price $2.59 $MSOX also had an inflow today consisting of 500,000 share creates valued at $1,285,000. Have a good sleep #MSOGang! 😊🥂💚 $GTBIF 69,372 💥 $CURLF 282,365 🌿 $TCNNF 61,326 🌞 $VRNOF 283,808 👀 $CRLBF 317,962 🧪 $TSNDF 278,260 🌪️ $GLASF 43,308 🏡 $JUSHF 208,668🔥 $CXXIF 107,157 🌻 $PLNH 135,904 🪐 $VREOF 58,098🪴 $GRUSF 25,642🍀 $AAWH 40,806 🚀 $VFF 22,800 🧑‍🌾 $SNDL 15,360🍁

A fairly simple update today for the @AdvisorShares psychedelic ETF with just 2 changes made to the $PSIL holdings for March 19, 2026 😊💚🥂 $DFTX (5,000) $RLMD (15,000)

Glass House Brands to Host Fourth Quarter and Full Year 2025 Earnings Call on March 24, 2026 after market close $GLAS $GLASF $GHBWF $MSOS globenewswire.com/news-release/2…

Yesterday @V_arrell asked me at the 31min mark👇about hemp's impact on state-legal. I mentioned Nevada was looking to crack down on loophole hemp/illicit that siphoned off ~$300M from state-legal. Fast fwd to today's news: regs, testing, & a ban on intoxicating hemp & synthetics:

Not spiking the football (and obv neither is the market) but two items dropped today that, read together, are worth noting for anyone tracking cannabis rescheduling. First: The Medicare CBD pilot launching April 1 will allow full-spectrum products, meaning trace THC is included. The government could have narrowed this to CBD isolate. They didn't. That's a quiet but meaningful acknowledgment of the entourage effect - that the combination of cannabinoids produces better clinical outcomes than CBD alone. You don't design a Medicare pilot around full-spectrum products without believing the THC interaction matters therapeutically. And before anyone says 'the hemp industry just lobbied for this' - Charlotte's Web would have taken isolate coverage and celebrated. The full-spectrum spec is a clinical design choice, not a lobbying win. Second: Rep. Reschenthaler (R-PA) introduced H.R.7987 today, creating a safe harbor for national securities exchanges to list cannabis companies and prohibiting federal adverse action against businesses that serve cannabis operators. Here's the dot-connect: Schedule I is defined as 'no currently accepted medical use.' The federal government is now covering full-spectrum cannabinoid products (including THC) for seniors through a physician-recommended Medicare pilot. You cannot hold both of those positions simultaneously forever. HHS already formally concluded in 2023 that cannabis has accepted medical use. The EO directed the AG to expedite rescheduling. The pilot is now building the real-world evidence record that makes DEA resistance increasingly indefensible. The rescheduling isn't done. 280E relief isn't here yet. But consider what today actually represents: on the same day a federal health agency quietly acknowledged that THC has therapeutic value by designing a Medicare pilot around it, a Republican congressman introduced legislation to let cannabis companies list on national exchanges. One is the scientific predicate. The other is the capital markets infrastructure. You don't build the second without the first eventually following. Cautious optimism is the right posture. But the architecture is taking shape

Rep. Eric Bell Introduces House Resolution Urging Rescheduling of Cannabis to Align with Federal Recommendations. Read more here: ow.ly/p3LH50YwqaE #gapol #gahouse

Fought for Canadian workers and Canadian interests on the world’s biggest podcast. Thank you @joerogan for an amazing conversation. Let’s get tariff-free trade. Sign up to watch it first: conservative.ca/cpc/sign-here-…

▶️ $CURLF @Curaleaf_Inc Chairman & CEO @Boris_Jordan 🗣️ "I calculate that if you took two of the large MSOs and you put them together, you'd save $200M within 12 months." 🎦 WATCH interview: youtube.com/live/yDbvx0r2L… 🌿 Cannabis ETFs 🌎 $YOLO 🇺🇸 $MSOS 📈 $SPY $QQQ $IWM #FinTwit

THE U.S. GOVERNMENT PATENTED CANNABINOIDS FOR BRAIN PROTECTION. WHY IS NO ONE TALKING ABOUT IT? In 2003, the U.S. government was awarded Patent 6,630,507: "Cannabinoids as Antioxidants and Neuroprotectants." It specifically mentions CBD, THC, and other cannabinoids as having the potential to: ✅ Reduce oxidative stress ✅ Protect brain cells ✅ Support recovery from stroke, trauma, and neurodegenerative diseases. What is oxidative stress? Your cells naturally produce free radicals — unstable molecules — when making energy. Stress, poor diet, smoking, pollution, alcohol, UV exposure, and infections increase free radicals. • When your body can't neutralize them fast enough, oxidative stress occurs. Over time, oxidative stress damages DNA, proteins, and cell membranes, contributing to: • Faster aging • Chronic inflammation • Low immunity • Brain & nerve decline. Cannabinoids act as powerful antioxidants, and help neutralize free radicals, calm inflammation, and protect your cells — sometimes even more effectively than classic antioxidants like vitamins C & E. Why the patent? Researchers realized cannabinoids could protect your cells and brain. That's why the government and pharma positioned early to secure rights for medicinal use. That’s why I grow my own landracebureau.com #cannabinoidscience #oxidativestress #neuroprotection #brainhealth #cellularhealth #antioxidants #endocannabinoidsystem #plantmedicine #healthyaging

$MSOS Medicare coverage SCOOP: Medicare Will Cover THC in Pilot Program - CMS spokesperson Cannabis Wire cannabiswire.com/newsletters/sc…

A bipartisan bill introduced in the U.S. House would allow marijuana businesses to access major national stock exchanges while also shielding a wide range of companies that provide services to the legal marijuana industry. themarijuanaherald.com/2026/03/bipart…

Cannabis Rescheduling: Will the Vault for Cannabis Banking and Financial Services Finally Be Opened? natlawreview.com/article/cannab…

Huge Win for $Glasf @kylekazanceo @grahamfarrar

The uplisting bill we have been asking for. $MSOS

A new government-funded study concludes that alcohol and tobacco are more harmful to users and to society than marijuana is—and that the biggest harm associated with cannabis is "organized criminal activity" in the illegal market. marijuanamoment.net/alcohol-and-to…

🚨 Safe Harbor Uplisting Bill Introduced to the House 🔗 congress.gov/bill/119th-con… 🔎 H.R.7987 - To prohibit Federal agencies from taking any adverse action against a person solely because the person provides business assistance to a cannabis-related legitimate business, to amend the Securities Exchange Act of 1934 to create a safe harbor for national securities exchanges to list the securities of issuers that are cannabis-related legitimate businesses, and for other purposes. 🔥-take: As we all know by now, plenty of time & effort can occur between introducing a bill and passing it. Noteworthy nonetheless! 🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS 📈 $SPY $QQQ $IWM #FinTwit

🚨🚨🚨BREAKING: NEW CANNABIS UPLISTING BILL, HR 7987, HAS BEEN FILED! The bill intends to amend the Securities Exchange Act of 1934 and allow the listing of securities for cannabis-related legitimate businesses $MSOS

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder $CMND $PSIL globenewswire.com/news-release/2…

Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client $BLO $BLOZF globenewswire.com/news-release/2…

Planet 13 Announces Release Date of Fourth Quarter 2025 Financial Results as March 25th, 2026, aftermarket. $PLTH $PLNH $MSOS globenewswire.com/news-release/2…